OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GSTK.PK56

Growth Stalk Holdings Corp

Drug RetailersVerified

Growth Stalk Holdings Corp has a basic capital structure with no dilution risk identified, as shares outstanding for both basic and diluted scenarios are equal at 30.9 million shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for comparison against industry_config preferred metrics or cohort medians, as the valuation snapshot is currently empty. This limits the ability to assess the company's performance relative to its peers in the Drug Retailers industry. The company's revenue concentration is not disclosed, but it operates in Oklahoma with three state-issued cannabis licenses and owns subsidiaries in multiple states, including Phenogene, LLC (Wyoming), Growers Consulting & Supply, LLC (Florida), and Southbound Sunshine, LLC (Oklahoma). This suggests a moderate geographic diversification strategy. Growth trajectory data is not available, as the outlook section lacks numeric deltas or revenue history. The company's plans for multi-state expansion remain aspirational without disclosed financial progress metrics. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. Dilution risk is currently low, but no adjustments or provenance data are available in custom_valuations to confirm this. Recent events and filings do not provide additional insight into the company's operations or financial position, as the source documents lack detailed disclosures beyond the basic financial snapshot.

30-day price · GSTK.PK-1.40 (-48.4%)
Low$1.26High$2.89Close$1.49As of10 May, 00:00 UTC
Profile
CompanyGrowth Stalk Holdings Corp
TickerGSTK.PK
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryDrug Retailers
AI analysis

Business. Growth Stalk Holdings Corp is a vertically integrated cannabis operator focused on solventless extraction, brand development, and cannabis-specific software infrastructure, operating in Oklahoma with plans for multi-state expansion.

Classification. Growth Stalk Holdings Corp is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Drug Retailers industry with a confidence level of 0.92.

Growth Stalk Holdings Corp has a basic capital structure with no dilution risk identified, as shares outstanding for both basic and diluted scenarios are equal at 30.9 million shares. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and returns data are not available for comparison against industry_config preferred metrics or cohort medians, as the valuation snapshot is currently empty. This limits the ability to assess the company's performance relative to its peers in the Drug Retailers industry. The company's revenue concentration is not disclosed, but it operates in Oklahoma with three state-issued cannabis licenses and owns subsidiaries in multiple states, including Phenogene, LLC (Wyoming), Growers Consulting & Supply, LLC (Florida), and Southbound Sunshine, LLC (Oklahoma). This suggests a moderate geographic diversification strategy. Growth trajectory data is not available, as the outlook section lacks numeric deltas or revenue history. The company's plans for multi-state expansion remain aspirational without disclosed financial progress metrics. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and the absence of going-concern language in source documents. Dilution risk is currently low, but no adjustments or provenance data are available in custom_valuations to confirm this. Recent events and filings do not provide additional insight into the company's operations or financial position, as the source documents lack detailed disclosures beyond the basic financial snapshot.
Key takeaways
  • Growth Stalk Holdings Corp operates in the Drug Retailers industry with a vertically integrated cannabis business model.
  • The company has a basic capital structure with no dilution risk identified.
  • Liquidity risk could not be assessed due to missing balance-sheet data.
  • Profitability and returns data are not available for comparison with industry benchmarks.
  • The company's geographic exposure includes Oklahoma, Wyoming, and Florida through its subsidiaries.
  • No recent events or detailed financial progress metrics are disclosed in the source documents.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
MetricGSTK.PKActivity
Op margin2.8% medp25 0.9% · p75 5.9%
Net margin1.8% medp25 0.3% · p75 3.6%
Gross margin24.1% medp25 13.8% · p75 31.4%
CapEx / revenue-2.0% medp25 -3.8% · p75 -1.0%
Debt / equity56.0% medp25 14.0% · p75 113.8%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:02 UTC#d23cb381
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:03 UTCJob: fbc57e61